A Multicenter Retrospective Study of the Safety and Efficacy of Nivolumab (Nivo) in Combination with Doxorubicin, Vinblastine, and Dacarbazine (AVD) for the Frontline Treatment of Advanced Stage Hodgkin Lymphoma (HL) – A Real-World Study